{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:10:34Z","timestamp":1780463434990,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["4533-25298"],"award-info":[{"award-number":["4533-25298"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.02.013","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T06:22:23Z","timestamp":1424240543000},"page":"1568-1577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses"],"prefix":"10.1016","volume":"33","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika A.","family":"Kalkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.02.013_bib0005","series-title":"Global polio eradication initiative","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0010","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.38.20586","article-title":"Insidious reintroduction of wild poliovirus into Israel, 2013","volume":"18","author":"Anis","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0015","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1093\/infdis\/jiu294","article-title":"Laboratory challenges in response to silent introduction and sustained transmission of wild type 1 poliovirus into Israel in 2013","volume":"210","author":"Shulman","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0020","article-title":"Modeling options to manage type 1 wild poliovirus imported into Israel in 2013","volume":"2014","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0025","series-title":"Poliovirus detected from environmental samples in Egypt","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0030","series-title":"Temporary recommendations to reduce international spread of poliovirus","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1539-6924.2012.01891.x","article-title":"Modeling population immunity to support efforts to end the transmission of live polioviruses","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/risa.12019","article-title":"Pre-eradication vaccine policy options for poliovirus infection and disease control","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0045","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1093\/infdis\/jit454","article-title":"Outbreaks of paralytic poliomyelitis during 1996\u20132012: the changing epidemiology of a disease in the final stages of eradication","volume":"210","author":"Mach","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0055","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/risa.12022","article-title":"Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs)","volume":"23","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/risa.12031","article-title":"Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/aje\/kwi206","article-title":"A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future","volume":"162","author":"Duintjer Tebbens","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/risa.12044","article-title":"Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses","volume":"23","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/erv.11.195","article-title":"Current polio global eradication and control policy options: perspectives from modeling and prerequisites for OPV cessation","volume":"11","author":"Thompson","year":"2012","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/infdis\/jit845","article-title":"Modeling the dynamics of oral poliovirus vaccine cessation","volume":"210","author":"Thompson","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/infdis\/jit838","article-title":"Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation","volume":"210","author":"Duintjer Tebbens","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/infdis\/jit844","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/infdis\/jit834","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0105","series-title":"Global polio eradication initiative: polio eradication and endgame strategic plan (2013\u20132018)","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/003335491212700104","article-title":"Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response","volume":"127","author":"Thompson","year":"2012","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2334-14-45","article-title":"The potential impact of expanding target age groups for polio immunization campaigns","volume":"14","author":"Duintjer Tebbens","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12879-015-0791-5","article-title":"Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination","volume":"15","author":"Kalkowska","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/infdis\/jit843","article-title":"Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination","volume":"210","author":"Kisjes","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0130","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu1136","article-title":"Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013","author":"Shulman","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0135","series-title":"RIVM rapport 150202001","article-title":"Vaccinatiegraad Rijksvaccinatieprogramma Nederland: Verslagjaar 2013 (in Dutch)","author":"van Lier","year":"2013"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0140","first-page":"124","article-title":"The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic","volume":"29","author":"Schaap","year":"1984","journal-title":"Prog Med Virol"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0145","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1086\/324327","article-title":"Poliovirus circulation among schoolchildren during the early phase of the 1992\u20131993 poliomyelitis outbreak in The Netherlands","volume":"184","author":"Oostvogel","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0150","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.36.20580","article-title":"Large ongoing measles outbreak in a religious community in the Netherlands since May 2013","volume":"18","author":"Knol","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2458-11-102","article-title":"Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study","volume":"11","author":"Ruijs","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0160","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1539-6924.2006.00831.x","article-title":"Retrospective cost-effectiveness analyses for polio vaccination in the United States","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(94)92091-5","article-title":"Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992\u20133","volume":"344","author":"Oostvogel","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0170","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson","year":"2008","journal-title":"Medscape J Med"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0175","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1542\/peds.2005-2358","article-title":"Decision analysis in planning for a polio outbreak in the United States","volume":"118","author":"Jenkins","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2014.864563","article-title":"National choices related to inactivated poliovirus vaccine, innovation, and the end game of global polio eradication","volume":"13","author":"Thompson","year":"2014","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.02.013_bib0185","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"J Am Med Assoc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T01:28:17Z","timestamp":1566350897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X15001796"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}